HATICE HASTURK, DDS, PH.D.
Dentist at Newton St, Boston, MA
License number
Massachusetts DF 10568
Category
Dentist
Type
Periodontics
Address
Address
100 E Newton St #G-107, Boston, MA 02118
Phone
(617) 638-4561
(617) 638-4799 (Fax)
(617) 638-4799 (Fax)
Organization information
See more information about HATICE HASTURK at bizstanding.comHatice Hasturk DDS,PHD
100 E Newton St, Boston, MA 02118
Industry:
Dentists
Phone:
(617) 638-4561 (Phone)
Hatice Hasturk
Professional information
Board Certified Periodontist And Scientist
Position:
Research Associate Investigator, Director of Center for Clinical and Translational Research at The Forsyth Institute
Location:
Greater Boston Area
Industry:
Higher Education
Work:
The Forsyth Institute
- 24 First Street, Cambridge, MA 02142 since Nov 2010
-
Research Associate Investigator, Director of Center for Clinical and Translational Research
Boston University
- 100 East Neton Street, Boston, MA 02118 Oct 1999 - Nov 2010
-
Associate Professor
Education:
Hacettepe University 1988 - 1995
DDS. Ph.D., Periodontology-Oral Biology
DDS. Ph.D., Periodontology-Oral Biology
Researcher At The Forsyth Institute
Position:
Researcher at The Forsyth Institute
Location:
Greater Boston Area
Industry:
Research
Work:
The Forsyth Institute
-
Researcher
Hatice Hasturk, Boston MA
Specialties:
Dentist
Address:
100 E Newton St, Boston, MA 02118
Dr. Hatice Hasturk, Boston MA - DDS (Doctor of Dental Surgery)
Specialties:
Periodontics
Address:
100 E Newton St STE G-107, Boston 02118
(617) 638-4561 (Phone), (617) 638-4799 (Fax)
(617) 638-4561 (Phone), (617) 638-4799 (Fax)
Languages:
English
Delivery Of H2 Antagonists
US Patent:
2011013, Jun 9, 2011
Filed:
Feb 15, 2011
Appl. No.:
13/027437
Inventors:
Thomas E. Van Dyke - West Roxbury MA, US
Michael Holick - Sudbury MA, US
Hatice Hasturk - Brighton MA, US
Michael Holick - Sudbury MA, US
Hatice Hasturk - Brighton MA, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
International Classification:
A61K 9/127, A61K 31/4164, A61K 31/426, A61K 31/341, A61P 1/02
US Classification:
424450, 514400, 514369, 514365, 514471
Abstract:
The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as NOVASOME® microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of the present invention may be used to treat any disease state or condition where local administration of H2 antagonists is beneficial.
Delivery Of H2 Antagonists
US Patent:
2008004, Feb 21, 2008
Filed:
Dec 20, 2005
Appl. No.:
11/793884
Inventors:
Thomas Van Dyke - West Roxbury MA, US
Michael Holick - Sudbury MA, US
Hatice Hasturk - Brighton MA, US
Michael Holick - Sudbury MA, US
Hatice Hasturk - Brighton MA, US
International Classification:
A61K 31/415, A61K 31/425, A61P 43/00
US Classification:
514369000, 514365000, 514396000
Abstract:
The present invention provides methods for treating or preventing periodontal disease in a mammal subject. The inventive methods comprise topically administering to the subject an effective amount of a H2 antagonist encapsulated in liposomes. Preferably, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as Novasome® microvesicles. The inventive methods may be used to treat and/or prevent gingivitis, periodontitis, aphthous ulcers, or herpetic stomatitis. Alternatively, the inventive methods may be used to treat and/or prevent a systemic disease associated with periodontal disease, such as cardiovascular diseases, pregnancy complications, and diabetes.
Delivery Of H2 Antagonists
US Patent:
2013010, May 2, 2013
Filed:
Dec 5, 2012
Appl. No.:
13/705471
Inventors:
Michael Holick - Sudbury MA, US
Hatice Hasturk - Brighton MA, US
Hatice Hasturk - Brighton MA, US
Assignee:
Trustees of Boston University - Boston MA
International Classification:
A61K 9/00
US Classification:
424450, 514400, 514370, 514365, 514471
Abstract:
The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as NOVASOME® microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of the present invention may be used to treat any disease state or condition where local administration of H2 antagonists is beneficial.